CXCL8 and melanoma: For example, dacarbazine, the standard therapy for melanoma, causes a “chemokine storm” of CXCL-8 [34] and other CXC chemokines of the same receptor signaling after massive cell death (unpublished data from our laboratory), which is one of the escape mechanisms for developing therapy resistance.